Myoelectric prostheses are technologically advanced medical devices designed to support individuals with limb loss by restoring functional movement. These systems interpret electromyographic (EMG) signals from residual muscles to control motorized components, offering enhanced precision and adaptability compared to conventional mechanical prostheses.
In Colombia, the INVIMA regulates the registration and commercialization of medical devices, including prosthetic technologies. For manufacturers, distributors, and clinical professionals aiming to introduce myoelectric systems into the national healthcare market, understanding the regulatory framework is key to ensuring compliance. In this article we examine the classification and grouping of myoelectric prostheses within the Colombian regulatory context.
Distinction by Risk Level and Technological Complexity
Not all prosthetic devices are classified equally under INVIMA. Their classification depends on the presence or absence of active components and the associated risk level.
Passive and Cosmetic Prostheses: Non-Technological Designs
These are non-powered, external prostheses intended primarily for functional replacement or cosmetic purposes. They do not include active mechanisms such as motors, batteries, or electrodes. Examples include:
- External limb prostheses for upper and lower extremities
- Mechanical finger prostheses for partial hand amputations
- Passive limb covers or cosmetic shells
According to INVIMA’s classification rules, these devices fall under Class I because they are non-invasive, external, and do not interact with internal body systems or involve electrical components. Their registration process is simplified due to their minimal risk profile.
Technologically Enhanced Prostheses: Powered and Signal-Responsive Systems
Prostheses that incorporate electrical components, such as batteries, electrodes, and motors, are subject to a higher classification due to their increased complexity and potential risks. These include:
- Myoelectric prostheses activated via EMG (Electromyography) signals
- Motorized joints (e.g., elbow, knee, ankle)
- Systems with rechargeable batteries or external power sources
Associated risks include:
- Battery overheating, leakage, or failure
- Electrode malfunction or skin irritation
- Signal misinterpretation affecting movement control
Under INVIMA’s framework, these devices are classified as Class IIa because they are active therapeutic devices that administer or exchange energy with the body. Their technological nature and direct impact on user mobility require more rigorous safety and performance validation.
Classification of Prosthetic Devices under INVIMA
According to INVIMA guidelines, prosthetic devices are classified according to their intended use, risk level, and technological complexity:
- Class I : External, passive prostheses such as cosmetic limb covers, mechanical finger prostheses, and standard external limb replacements. These are non-invasive and serve primarily as mechanical substitutes.
- Class IIa: Active prostheses such as myoelectric systems, which rely on electrical signals and powered components to restore mobility. Their classification reflects the need for stricter regulatory oversight, especially regarding safety, performance, and durability of electronic components.
This classification reflects the need for greater regulatory oversight, especially regarding safety, performance, and durability of electronic components.
Grouping Strategies for Regulatory Submissions
INVIMA permits grouping of prosthetic models under a single registration when they share core characteristics and are manufactured by the same entity. For myoelectric prostheses, grouping may be based on:
1. Functional Configuration
- Modular combinations (e.g., hand-wrist-elbow or ankle-knee-hip)
- Manual vs. electronic components
2. Control Mechanism
- Myoelectric activation via EMG signals
- Mechanical/manual articulation
3. Manufacturer Consistency
Grouping is allowed when all models are produced by the same manufacturer under a unified regulatory submission.
Conclusion
Myoelectric prostheses provide important functional benefits in rehabilitation, supporting mobility and control for people with limb loss. In Colombia, registering and marketing these devices requires a clear understanding of INVIMA classification rules, grouping, and compliance with labeling and packaging requirements.
For guidance on the registration of prosthetic devices or other medical technologies in the Colombian market, you can reach us at contact@veraqueconsulting.com or consult our guidelines.
Seeking prostheses distributors? Access our database – a comprehensive resource for identifying qualified partners in the field.